Drug industry insiders are questioning whether Sen. Bernie Sanders’ proposal to cut pharma patent protections if drug prices are too high will be effective.
Drug industry insiders are questioning whether Sen. Bernie Sanders’ proposal to cut pharma patent protections if drug prices are too high will be effective.